• Mullerian agenesis (Mayer-Rokitansky-Kuster-Hauser syndrome – MRKH): diagnostics, management and treatment Number 728 • January 2018 (Replaces the opinion of the Committee in issue 562, May 2013)

Mullerian agenesis (Mayer-Rokitansky-Kuster-Hauser syndrome – MRKH): diagnostics, management and treatment Number 728 • January 2018 (Replaces the opinion of the Committee in issue 562, May 2013)

HEALTH OF WOMAN. 2018.3(129):132–137

The Adolescent Health Committee, North American Society of Pediatrics and Adolescent Gynecology, endorses this document. This document was developed by the Committee of the American College of Obstetricians and Gynecologists for Adolescent Health in collaboration with Committee member Anne-Marie Amis Oelschlager, MD.
Abbreviated version Adapted - S.А. Shurpyak


1. Fontana L, Gentilin B, Fedele L, Gervasini C, Miozzo M. 2017. Genetics of Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Clin Genet 91:233–46. https://doi.org/10.1111/cge.12883; PMid:27716927

2. Sarpel U, Palmer SK, Dolgin SE. 2005. The incidence of complete androgen insensitivity in girls with inguinal hernias and assessment of screening by vaginal length measurement. J Pediatr Surg 40:133–6; discussion 136–7. https://doi.org/10.1016/j.jpedsurg.2004.09.012; PMid:15868573

3. DeebA,HughesIA.Inguinalherniainfemaleinfants:acue to check the sex chromosomes? BJU Int 2005. 96:401–3. https://doi.org/10.1111/j.1464-410X.2005.05639.x; PMid:16042738

4. Patel V, Casey RK, Gomez-Lobo V. 2016. Timing of gonadectomy in patients with complete androgen insensitivity syndrome-current recommendations and future directions. J Pediatr Adolesc Gynecol 29:320–5. https://doi.org/10.1016/j.jpag.2015.03.011; PMid:26428189

5. Lee PA, Nordenstrom A, Houk CP, Ahmed SF, Auchus R, Baratz A et al. 2016. Global disorders of sex development update since 2006: perceptions, approach and care. Global DSD Update Consortium. published erratum appears in Horm Res Paediatr 2016. 85:180. Horm Res Paediatr 85:158–80. https://doi.org/10.1159/000442975; PMid:26820577

6. Kim SM, Rhee JH. 2015. A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med 42:72–6. https://doi.org/10.5653/cerm.2015.42.2.72; PMid:26161337 PMCid:PMC4496435

7. Costa-Santos M, Kater CE, Auchus RJ. 2004. Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group. J Clin Endocrinol Metab 89:49–60. https://doi.org/10.1210/jc.2003-031021; PMid:14715827

8. Preibsch H, Rall K, Wietek BM, Brucker SY, Staebler A, Claussen CD et al. 2014. Clinical value of magnetic resonance imaging in patients with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome: diagnosis of associated malformations, uterine rudiments and intrauterine endometrium. Eur Radiol 24:1621–7. https://doi.org/10.1007/s00330-014-3156-3; PMid:24737529

9. Michala L, Aslam N, Conway GS, Creighton SM. 2010. The clandestine uterus: or how the uterus escapes detection prior to puberty. BJOG 117:212–5. https://doi.org/10.1111/j.1471-0528.2009.02413.x; PMid:20002397

10. Laufer MR. Struturalab normaliti esof the femalereproductive tract. In: Emans SJ, Laufer MR, editors. Pediatric and adolescent gynecology. 6th ed. Philadelphia (PA), Wolters Kluwer; Lippincott Williams & Wilkins. 2012: 177–237.

11. Cho MK, Kim CH, Oh ST. 2009. Endometriosis in a patient with Rokitansky-Kuster-Hauser syndrome. J Obstet Gynaecol Res 35:994–6. https://doi.org/10.1111/j.1447-0756.2009.01025.x; PMid:20149055

12. Oppelt P,Renner SP,Kellermann A,Brucker S,Hauser GA, Ludwig KS et al. 2006. Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging. Hum Reprod 21:792–7. https://doi.org/10.1093/humrep/dei381; PMid:16284062

13. Kapczuk K, Iwaniec K, Friebe Z, Kedzia W. 2016. Congenital malformations and other comorbidities in 125 women with Mayer-Rokitansky-Kuster-Hauser syndrome. Eur J Obstet Gynecol Reprod Biol 207:45–9. https://doi.org/10.1016/j.ejogrb.2016.10.014; PMid:27825026

14. Rall K, Eisenbeis S, Henninger V, Henes M, Wallwiener D, Bonin M et al. 2015. Typical and atypical associated findings in a group of 346 patients with Mayer-Rokitansky-Kuester- Hauser Syndrome. J Pediatr Adolesc Gynecol 28:362–8. https://doi.org/10.1016/j.jpag.2014.07.019; PMid:26148785

15. Breech L. 2010. Gynecologic concerns in patients with anorectal malformations. Semin Pediatr Surg 19:139–45. https://doi.org/10.1053/j.sempedsurg.2009.11.019; PMid:20307850

16. Patterson CJ, Crawford R, Jahoda A. 2016. Exploring the psychological impact of Mayer-Rokitansky-Kuster-Hauser syndrome on young women: an interpretative phenomenological analysis. J Health Psychol 21:1228–40. https://doi.org/10.1177/1359105314551077; PMid:25293965

17. Ernst ME, Sandberg DE, Keegan C, Quint EH, Lossie AC, Yashar BM. 2016. The lived experience of MRKH: sharing health information with peers. J Pediatr Adolesc Gynecol 29:154–8. https://doi.org/10.1016/j.jpag.2015.09.009; PMid:26453829

18. PolandML, EvansTN.Psychologicaspectsofvaginalagen- esis. J Reprod Med 1985;30:340–4. PMid:4009551

19. Friedler S, Grin L, Liberti G, Saar-Ryss B, Rabinson Y, Meltzer S. 2016. The reproductive potential of patients with Mayer-Rokitansky-Kuster-Hauser syndrome using gestational surrogacy: a systematic review. Reprod Biomed Online 32:54–61. https://doi.org/10.1016/j.rbmo.2015.09.006; PMid:26626805

20. Petrozza JC, Gray MR,Davis AJ, Reindollar RH. 1997. Congenital absence of the uterus and vagina is not commonly transmitted as a dominant genetic trait: outcomes of surrogate pregnancies. Fertil Steril 67:387–9. https://doi.org/10.1016/S0015-0282(97)81927-9

21. Carson SA, Simpson JL, Malinak LR, Elias S, Gerbie AB, Buttram VC Jr et al. 1983. Heritable aspects of uterine anomalies. II. Genetic analysis of müllerian aplasia. Fertil Steril 40:86–90. https://doi.org/10.1016/S0015-0282(16)47182-7

22. Brannstrom M, Johannesson L, Bokstrom H, Kvarnstrom N, Molne J, Dahm­Kahler P et al. 2015. Livebirth after uterus transplantation. Lancet 385:607–16. https://doi.org/10.1016/S0140-6736(14)61728-1; https://doi.org/10.1016/S0140-6736(15)61098-4

23. Johannesson L, Kvarnstrom N, Molne J, Dahm­Kahler P, Enskog A, Diaz­Garcia C et al. 2015. Uterus transplantation trial: 1­year outcome. Fertil Steril 103:199–204. https://doi.org/10.1016/j.fertnstert.2014.09.024; PMid:25439846

24. Willemsen WN, Kluivers KB. 2015. Long­term results of vaginal construction with the use of Frank dilation and a peritoneal graft (Davydov procedure) in patients with Mayer­ Rokitansky­Kuster syndrome. Fertil Steril 103:220–7.e1. https://doi.org/10.1016/j.fertnstert.2014.10.014; PMid:25455533

25. Gargollo PC, Cannon GM Jr, Diamond DA, Thomas P, Burke V, Laufer MR. 2009. Should progressive perineal dilation be considered first line therapy for vaginal agenesis? J Urol 182:1882–9. https://doi.org/10.1016/j.juro.2009.03.071; PMid:19695600

26. Roberts CP, Haber MJ, Rock JA. 2001. Vaginal creation for mül­ lerian agenesis. Am J Obstet Gynecol 185:1349–52; discussion 1352–3. https://doi.org/10.1067/mob.2001.119075; PMid:11744908

27. Edmonds DK, Rose GL, Lipton MG, Quek J. 2012. Mayer­ Rokitansky­Kuster­Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators. Fertil Steril 97:686–90. https://doi.org/10.1016/j.fertnstert.2011.12.038; PMid:22265001

28. Patel V, Hakim J, Gomez­Lobo V, Oelschlager AA. Providers’ experiences with vaginal dilator training for patients with vaginal agenesis. J Pediatr Adolesc Gynecol 2017. Available at: http://www.sciencedirect.com/science/ article/pii/S1083318817302656. Retrieved2017, September 14.

29. Adeyemi­Fowode OA, Dietrich JE. 2017. Assessing the experience of vaginal dilator use and potential barriers to ongoing use among a focus group of women with Mayer­ Rokitansky­Kuster­Hauser Syndrome. J Pediatr Adolesc Gynecol 30:491–4. https://doi.org/10.1016/j.jpag.2017.02.002; PMid:28216131

30. Oelschlager AM, Debiec K, Appelbaum H. 2016. Primary vaginal dilation for vaginal agenesis: strategies to anticipate challenges and optimize outcomes. Curr Opin Obstet Gynecol 28:345–9. https://doi.org/10.1097/GCO.0000000000000302; PMid:27454852

31. Callens N, De Cuypere G, De Sutter P, Monstrey S, Weyers S, Hoebeke P et al. 2014. An update on surgical and non­surgical treatments for vaginal hypoplasia. Hum Reprod Update 20:775–801. https://doi.org/10.1093/humupd/dmu024; PMid:24899229

32. McVearry ME, Warner WB. 2011. Use of physical therapy to augment dilator treatment for vaginal agenesis. Female Pelvic Med Reconstr Surg 17:153–6. https://doi.org/10.1097/SPV.0b013e31821bcd83; PMid:22453790

33. Moen MH. 2014. Vaginal agenesis treated by coital dilatation in 20 patients. Int J Gynaecol Obstet 125:282–3. https://doi.org/10.1016/j.ijgo.2014.01.007; PMid:24630858

34. Callens N, Weyers S, Monstrey S, Stockman S, van Hoorde B, van Hoecke E et al. 2014. Vaginal dilation treatment in women with vaginal hypoplasia: a prospective one­year follow­up study. Am J Obstet Gynecol 211:228.e1–12. https://doi.org/10.1016/j.ajog.2014.03.051; PMid:24681288

35. Michala L, Strawbridge L, Bikoo M, Cutner AS, Creighton SM. 2013. Lower urinary tract symptoms in women with vaginal agenesis. Int Urogynecol J 24:425–9. https://doi.org/10.1007/s00192-012-1870-4; PMid:22797462

36. Laufer MR. 2002. Congenital absence of the vagina: in search of the perfect solution. When, and by what technique, should a vagina be created? Curr Opin Obstet Gynecol 14:441–4. https://doi.org/10.1097/00001703-200210000-00001; PMid:12401969

37. Brucker SY, Gegusch M, Zubke W, Rall K, Gauwerky JF, Wallwiener D. 2008. Neovagina creation in vaginal agenesis: development of a new laparoscopic Vecchietti­based procedure and optimized instruments in a prospective comparative interventional study in 101 patients. Fertil Steril 90:1940–52. https://doi.org/10.1016/j.fertnstert.2007.08.070; PMid:18061172

38. Borruto F, Chasen ST, Chervenak FA, Fedele L. 1999. The Vecchietti procedure for surgical treatment of vaginal agenesis: comparison of laparoscopy and laparotomy. Int J Gynaecol Obstet 64:153–8. https://doi.org/10.1016/S0020-7292(98)00244-6

39. AdamyanLV. 1995. Laparoscopicmanagementofvaginalaplasia with or without functional noncommunicating rudimentary uterus. In: Arregui ME, Fitzgibbons RJ Jr, Katkhouda N, McKernan JB, Reich H, editors. Principles of laparoscopic surgery: basic and advanced techniques. New York (NY), Springer­Verlag: 646–51.

40. Davydov SN, Zhvitiashvili OD. 1974. Formation of vagina (col­ popoiesis) from peritoneum of Douglas pouch. Acta Chir Plast 16:35–41.

41. Adamyan LV. 2000. Therapeutic and endoscopic perspectives. In: Nichols DH, Clarke­Pearson DL, editors. Gynecologic, obstetric, and related surgery. 2nd ed. St. Louis (MO), Mosby: 1209–17.

42. Allen LM, Lucco KL, Brown CM, Spitzer RF, Kives S. 2010. Psychosexual and functional outcomes after creation of a neovagina with laparoscopic Davydov in patients with vaginal agenesis. Fertil Steril 94:2272–6. https://doi.org/10.1016/j.fertnstert.2010.02.008; PMid:20236638

43. Workowski KA, Bolan GA. 2015. Sexually transmitted diseases treatment guidelines, 2015. Centers for Disease Control and Prevention. published erratum appears in MMWR Recomm Rep 2015. 64:924. MMWR Recomm Rep 64(RR­03):1–137. PMid:26042815 PMCid:PMC5885289

44. Frega A, Scirpa P, Sopracordevole F, Biamonti A, Bianchi P, De Sanctis L et al. 2011. Impact of human papillomavirus infection on the neovaginal and vulval tissues of women who underwent surgical treatment for Mayer­Rokitansky­Kuster­Hauser syndrome. Fertil Steril 96:969–73. https://doi.org/10.1016/j.fertnstert.2011.07.1099;PMid:21820652

45. Human papillomavirus vaccination. Committee Opinion 704. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017. 129:e173–8. https://doi.org/10.1097/AOG.0000000000002052; PMid:28346275